Aripiprazole and Delusional Disorder.

Area of Science:

• Psychiatry and Behavioral Sciences
• Neuroscience
• Pharmacology

Background:

• Delusional disorder is a rare psychotic illness distinct from schizophrenia, characterized by persistent, non-bizarre delusions.
• Limited systematic research exists for delusional disorder, with treatment guidelines primarily based on case reports and small series.
• Antipsychotic medications are the standard treatment, but evidence comparing specific agents is scarce.

Observation:

• A case of delusional disorder is presented where the patient did not respond to risperidone treatment.
• The patient experienced significant improvement after switching to aripiprazole therapy.
• This observation highlights potential differential responses to antipsychotic medications in delusional disorder.

Findings:

• Aripiprazole demonstrated marked efficacy in a patient with delusional disorder refractory to risperidone.
• The patient's delusional symptoms resolved or significantly diminished with aripiprazole treatment.
• This suggests aripiprazole may be a valuable therapeutic option for delusional disorder.

Implications:

• Aripiprazole's efficacy warrants further investigation as a potential treatment for delusional disorder.
• The drug's combined dopaminergic and serotonergic activity may underlie its effectiveness in this condition.
• Further clinical trials are needed to establish aripiprazole's role in managing delusional disorder.